Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy

다국어 초록 (Multilingual Abstract)

Objective: The purpose of this study was to evaluate the prognostic significance of tumor volume assessed by pretreatment MRI in stage IIB cervical cancer patients with concurrent chemoradiation therapy.
Methods: A retrospective chart review was performed on seventy five patients with cervical cancer who were treated with concurrent weekly cisplatin (40 mg/m2) and radiotherapy between January 2000 and April 2007. Potential prognostic factors were age, chemotherapy numbers, histology, tumor diameter and volume, lymph node (LN)involvement and pretreatment squamous cell carcinoma antigen (SCC-Ag) levels.
Results: The median follow-up time was 55 months (range, 8 to 104 months). The median tumor size and volume (range) were 4.5 cm (2 to 10) and 33.1 mL (4.2 to 392.7), respectively. Pelvic LN enlargement rate was 58.7%.
Para-aortic LN enlargement rate was 14.7%. Using multivariate analysis, a tumor volume (＞33 mL, p=0.025), pelvic LN enlargement (p=0.044) revealed a significantly unfavorable outcome on overall survival. PFS was influenced by tumor histology (p＜0.001), pelvic LN enlargement (p=0.015) and pretreatment SCC-Ag levels (p=0.018). We found that 22 (29.3%) patients had recurrences and 14 (18.7%) patients died of disease. The 5-year overall survival rate was 80.6% (standard error, 4.9%) and 5-year PFS rate was 71.3% (standard error, 5.3%).
Conclusion: Tumor volume and pelvic LN involvement showed possibility to predict overall survival in patient with stage ⅡB cervical cancer. Optimal tumor volume and pelvic LN assessment by pretreatment MRI might be helpful to predict treatment outcome.

참고문헌 (Reference)

1 Amendola MA, "Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183" 23 : 7454-7459, 2005

2 Ogino I, "The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy" 16 : 1094-1100, 2006

3 Inoue T, "The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB" 65 : 1923-1927, 1990

4 Eifel PJ, "The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix" 29 : 9-16, 1994

5 Micke O, "The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy" 25 : 1663-1666, 2005

6 Lea JS, "Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival" 84 : 115-119, 2002

7 Burghardt E, "Results of surgical treatment of 1028 cervical cancers studied with volumetry" 70 : 648-655, 1992

8 Hricak H, "Radiology in invasive cervical cancer" 167 : 1101-1108, 1996

9 Suprasert P, "Radical hysterectomy for stage IIB cervical cancer: a review" 15 : 995-1001, 2005

10 Molina R, "Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer" 24 : 156-164, 2003

11 Tinga DJ, "Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB" 39 : 175-180, 1990

12 Yu KK, "Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging" 171 : 707-711, 1998

13 Choi SH, "Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study" 28 : 620-627, 2004

14 Oellinger JJ, "Pre-operative staging of cervical cancer:comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results" 122 : 82-91, 2000

15 Rose PG, "Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study" 17 : 41-45, 1999

16 National Cancer Institute, "NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival"

17 Takeda N, "Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy" 81 : 1144-1151, 2002

18 Mayr NA, "Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging" 52 : 14-22, 2002

19 Ebner F, "Magnetic resonance imaging in cervical carcinoma: diagnosis, staging, and follow-up" 10 : 22-42, 1994

20 Sakuragi N, "Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy" 85 : 1547-1554, 1999

21 Scheidler J, "Imaging of cancer of the cervix" 40 : 577-590, 2002

22 Kamura T, "Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection:an analysis with mathematical statistics" 3 : 219-225, 1993

23 Zaino RJ, "Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study" 69 : 1750-1758, 1992

24 Hatano K, "Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging" 45 : 639-644, 1999

25 Narayan K, "Estimation of tumor volume in cervical cancer by magnetic resonance imaging" 26 : 163-168, 2003

26 Kawagoe T, "Clinical significance of tumor size in stage IB and II carcinoma of the uterine cervix" 9 : 421-426, 1999

27 Thoms WW Jr, "Bulky endocervical carcinoma: a 23-year experience" 23 : 491-499, 1992

28 Narayan K, "A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment" 11 : 263-271, 2001